Skip Navigation

Scientific Advisory Board

Scientific Advisory Board

The Packard Center's scientific advisors are internationally prominent scientists and clinicans with expertise in basic cell biology, neurodegeneration, clinical investigation and the workings of the biopharmaceutical industry. They set the Center's research agenda as well as approve all ALS research grants.

David Borchelt, PhD
Molecular Mechanisms of Neurodegenerative Disease
Director, SantaFe Health Alzheimer's Disease Research Center
McKnight Brain Institute
University of Florida
Gainesville, FL

Steven Burden, PhD
Development and Diseases of the Neuromuscular Synapse
Professor & Coordinator
Molecular Neurobiology Program
Skirball Institute
Helen & Martin S. Kimmel Center for Biology & Medicine
NYU Medical School
New York, NY

Don W. Cleveland, PhD
Transgenic Models of ALS and Mechanisms of SOD1 Toxicity
Laboratory of Cell Biology
Ludwig Institute for Cancer Research
University of California in San Diego
San Diego, CA

Thomas A. Cooper, MD
Microsatellite expansion disease, RNA binding protein function
S. Donald Greenberg Professor
Department of Pathology and Immunology
Baylor College of Medicine
Houston, TX

Beverly Davidson, PhD
Research focus: Inherited genetic diseases that cause central nervous system dysfunction
Children’s Hospital of Philadelphia
Philadelphia, PA

Kenneth Fischbeck, MD
Neurogenetics Branch Chief
National Institute of Neurological Disorders and Stroke
Bethesda, MD

Aaron D. Gitler, PhD
Mechanisms of Neurodegenerative Disease
Department of Genetics
Stanford University School of Medicine
Stanford, CA

Diane E. Merry, PhD
Thomas Jefferson University
Philadelphia, PA

Harry Orr, PhD
Triple Repeat Disease, Neurodegeneration
Department of Laboratory Medicine and Pathology
University of Minnesota
Minneapolis, MN

Mahendra S. Rao, MD, PhD
Stem Cell Biology
iPSC Chief
Laboratory of Stem Cell Biology/Center for Regenerative Medicine National Institutes of Health
Bethesda, MD

Wim Robberecht, MD, PhD
Motor Neuron Degeneration, Molecular Genetics
University of Leuven

Christopher E. Shaw, MBChB, MD
Research focus: Genetic, molecular, and cellular studies of motor neuron disorders
Professor of Neurology and Neurogenetics
Director, Maurice Wohl Clinical Neuroscience Institute
Institute of Psychiatry, Psychology and Neuroscience
King's College London and King's Health Partners
London, England

Sangram Sisodia, PhD
Protein Interactions, Alzheimer's Disease, Neurodegeneration
Departments of Neurobiology, Pharmacology & Cell Physiology
University of Chicago
Chicago, IL

Maurice Swanson, PhD
RNA-mediated Disease Mechanisms
Professor, Department of Molecular Genetics and Microbiology and the Genetics Institute
Associate Director, Center for NeuroGenetics
University of Florida
Gainesville, FL

Frank S. Walsh, PhD
Nervous System Development and Regeneration
CEO, Ossianix Inc.
Philadelphia, PA

Our Experts

Johns Hopkins University
Neurologist Charlotte Sumner has a long history of studying neuromuscular disorders. In particular, she has focused her attention on caring for patients with inherited motor neuron and peripheral nerve disorders such as spinal muscular atrophy and Charcot-Marie-Tooth disease. Her work on the molecular pathogenesis of spinal muscular atrophy and the development of therapeutics may provide important clues for those with ALS.
Udai Pandey, PhD

Our Experts

Udai Pandey, PhD
Dr. Pandey's goal is to understand how the FUS/TLS gene promotes ALS in fruit flies, which may shed clearer light on both familial and sporadic ALS in patients.
Meet Our Experts